Advertisement

Topics

AstraZeneca ups its mRNA stake through €25m Ethris deal

08:15 EDT 22 Aug 2017 | in-PharmaTechnologis

Original Article: AstraZeneca ups its mRNA stake through €25m Ethris deal

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca ups its mRNA stake through €25m Ethris deal"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...